Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has closed its previously announced registered direct offering ...
Anthony Thurston's decades of experience includes multiple technical leadership positions at Tesla, BASF, and Apple. He joins ...
U.S. stocks traded mixed midway through trading, with the S&P 500 and Nasdaq Composite edging higher on Wednesday. The Dow ...
Israel-based Augury Inc., a provider of internet of things sensors and artificial intelligence to predict machine repairs, ...
U.S. stocks traded lower this morning, with the Dow Jones index falling around 150 points on Wednesday. The Dow traded down 0 ...
The federal agencies responsible for implementing the No Surprises Act (NSA) independent dispute resolution (IDR) process previously notified certified IDR entities that they are permitted to consider ...
Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced its intention to initiate a clinical study on the combination of the ...
6d
Zacks.com on MSNMedtronic (MDT) Tops Q3 Earnings EstimatesMedtronic (MDT) came out with quarterly earnings of $1.39 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.30 per share a year ago. These figures are ...
Allurion Technologies Inc. is cleared by regulators in France to resume sales of its swallowable gastric balloon to treat ...
The mean of analysts' price targets for Allurion Technologies, Inc. (ALUR) points to a 374.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ...
Allurion Technologies, Inc. (ALUR) closed the last trading session at $6.04, gaining 58.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results